perifosine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
Studies (perifosine) | Trials (perifosine) | Recent Studies (post-2010) (perifosine) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
---|---|---|---|---|---|
245 | 31 | 140 | 6,010 | 10 | 772 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engel, J; Hilgard, P; Klenner, T; Kutscher, B; Nössner, G; Stekar, J | 1 |
1 other study(ies) available for perifosine and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
D-21266, a new heterocyclic alkylphospholipid with antitumour activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1997 |